Yi Gangxiao signed a share transfer letter of intent to acquire 55.3% stake in Chengdu Xintong Wangyi Medical Science and Technology Development Co., Ltd. from Vanfund Urban Investment and Development Co., Ltd. (SZSE:000638) on February 12, 2020. As on July 1, 2021, Yi Gangxiao and Li Peng signed the asset transfer agreement to acquire 55.3% stake in Chengdu Xintong Wangyi Medical Science and Technology Development Co., Ltd. from Vanfund Urban Investment and Development Co., Ltd. (SZSE:000638) for approximately CNY 170 million. As per the agreement, in the first transaction, the company intends to sell 10% of the equity of Xintong Wangyi to Yi Gangxiao for CNY 31,231,000. The estimated value of the transfer price for the proposed sale of 10% of Xintong Wangyi's equity to Li Peng is CNY 31,231,000. In the second transaction, the company intends to sell 35.3% of the shares in Xintong Wangyi to Li Peng at an estimated transfer price of CNY 110,245,430. On June 30, 2021, Xintong Wangyi's shareholders' meeting approved this transfer. On July 1, 2021, the 27th session of the company's 9th directorate approved this transaction. The transaction still needs to be approved by the shareholders of Vanfund Urban Investment. As of May 31, 2021, Chengdu Xintong Wangyi Medical Science and Technology Development reported total assets of CNY 193.3902 million and total owners equity of CNY 72.1152 million. Kaiyuan Securities Co., Ltd. acted as financial advisor, Beijing Hairun Law Firm acted as legal advisor and ZhongXingCaiGuangHua CPA Office Co. Ltd acted as accounted to Vanfund Urban.

Yi Gangxiao completed the acquisition of 55.3% stake in Chengdu Xintong Wangyi Medical Science and Technology Development Co., Ltd. from Vanfund Urban Investment and Development Co., Ltd. (SZSE:000638) on December 8, 2021.